Oman Pharmaceuticals and Healthcare Report

 Published On: Sep, 2016 |    No of Pages: 75 |  Published By: BMI Pharmaceuticals and Healthcare | Format: PDF
Request Free Sample
BMI View: The Oman Ministry of Health's decision to postpone the latest phase of medicine price reductions highlights the opaque nature of the country's pharmaceutical sector. Over the long term, Oman's population will benefit from more affordable healthcare services as even more medicines are reduced in price, however the impact on drugmaker's profit margins will continue to come under question. Nonetheless, Oman's evolving demographic and epidemiological profile will act as key drivers of growth within the country's pharmaceuticals and healthcare markets over the coming years, supported by an expanding private sector and the government's ongoing commitment to advancing healthcare.

Headline Expenditure Projections
-Pharmaceuticals: OMR242mn (USD628mn) in 2015 to OMR257mn (USD668mn) in 2016; 6.2% in local currency and US dollar terms. Forecast in line with Q316.
Healthcare: OMR1.15bn (USD3.00bn) in 2015 to OMR1.21bn (USD3.15bn) in 2016; +4.9% in local currency and US dollar terms. Forecast in line with Q316.

Risk/Reward Index
In our Q416 Pharmaceutical Risk/Reward Index (RRI) Oman's score of 47.6 out of 100 matches its score last quarter, yet moves down one position to 11th place out of 31 countries analysed in the whole Middle East and Africa (MEA) region. Regionally, Oman ranks relatively poorly compared to the other Gulf States
- only Iraq is positioned lower. Oman has limited longer-term commercial potential due to its small population, low per capita spending on pharmaceuticals and the fact that the government is responsible for the bulk of healthcare costs, which will increase the need for cost containment in the coming years.
BMI Industry View ....... 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Oman 2014-2020) . . . . . 7
SWOT .... 9
Industry Forecast ...... 12
Pharmaceutical Market Forecast  12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Oman 2012-2020) . . 14
Healthcare Market Forecast ...... 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) . . . 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) . . 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) . 18
Prescription Drug Market Forecast .... 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) . . . . 20
Patented Drug Market Forecast . 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) . 22
Generic Drug Market Forecast .. 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) . . 24
OTC Drug Market Forecast ....... 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Oman 2012-2020) . . . 26
Pharmaceutical Trade Forecast . 27
Table: Pharmaceutical Trade Data And Forecasts (Oman 2014-2020) . 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Oman 2014-2020) . . . 29
Industry Risk/Reward Index ..... 30
Middle East and Africa Risk/Reward Index - Q4 2016 ..... 30
Oman Risk/Reward Index .. 38
Rewards ....... 38
Risks .... 38
Regulatory Review .... 40
Intellectual Property Issues ...... 41
Pricing Regime ...... 42
Reimbursement Regime ... 43
Market Overview ....... 44
Healthcare Sector .. 45
Table: Healthcare Resources (Oman 2010-2015) 47
Table: Healthcare Personnel (Oman 2010-2015) 47
Table: Healthcare Activity (Oman 2010-2015) . . . 48
Research & Development  48
Clinical Trials ....... 49
Epidemiology  50
Competitive Landscape .... 54
Research-Based Industry . 54
Table: Multinational Market Activity . 55
Generic Drugmakers ...... 56
Pharmaceutical Distribution .... 57
Pharmaceutical Retail Sector ... 57
Company Profile  58
National Pharmaceutical Industries .... 58
Zynova/Oman Pharmaceutical Products Company . 61
Demographic Forecast ..... 64
Table: Population Headline Indicators (Oman 1990-2025) . . 65
Table: Key Population Ratios (Oman 1990-2025) . . . . . 65
Table: Urban/Rural Population & Life Expectancy (Oman 1990-2025) . 66
Table: Population By Age Group (Oman 1990-2025) . . 66
Table: Population By Age Group % (Oman 1990-2025) . . . . . 67
Glossary ..... 69
Methodology ...... 71
Pharmaceutical Expenditure Forecast Model ...... 71
Healthcare Expenditure Forecast Model ..... 71
Notes On Methodology .... 72
Risk/Reward Index Methodology ....... 73
Index Overview ...... 74
Table: Pharmaceutical Risk/Reward Index Indicators . 74
Indicator Weightings ...... 75
If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.